Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Vaginal Atrophy and Sexual Function in Post-menopausal Women
IRCT20160602028220N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in vaginal atrophy and female sexual dysfunction (FSD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Improvement in vaginal atrophy and Improvement in sexual function. Started Feb 2018; status: completed.
02
Drugs
oxytocin
03
Conditions
vaginal atrophyfemale sexual dysfunction (FSD)
Beyond the preview
Go deeper on IRCT20160602028220N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160602028220N2.